
Juno Metabolomics is a next-generation metabolomics company that offers an integrated, automated, and connected platform combining miniaturized chip-based mass spectrometry data generation with cloud-based bioinformatics. Their technology digitizes metabolomics data, enabling reproducible, instantly shareable, and easily integrated results with clinical databases, advancing precision medicine. The company provides products such as the JUNO Integrative Metabolomics Platform, JUNO Informatics Systems, and a Viral Surveillance Platform including JunoCOVID-Dx. Their services include metabolomics, lipidomics, quantitative assays, and structure elucidation with expertise in kidney disease, diabetes, and medical cannabis. Juno Metabolomics targets clinical and research customers, leveraging AI and cloud computing for scalable, tailored statistical analysis and diagnostics solutions, including COVID-19 rapid testing and chronic disease diagnostics.

Juno Metabolomics is a next-generation metabolomics company that offers an integrated, automated, and connected platform combining miniaturized chip-based mass spectrometry data generation with cloud-based bioinformatics. Their technology digitizes metabolomics data, enabling reproducible, instantly shareable, and easily integrated results with clinical databases, advancing precision medicine. The company provides products such as the JUNO Integrative Metabolomics Platform, JUNO Informatics Systems, and a Viral Surveillance Platform including JunoCOVID-Dx. Their services include metabolomics, lipidomics, quantitative assays, and structure elucidation with expertise in kidney disease, diabetes, and medical cannabis. Juno Metabolomics targets clinical and research customers, leveraging AI and cloud computing for scalable, tailored statistical analysis and diagnostics solutions, including COVID-19 rapid testing and chronic disease diagnostics.